Thomas Stephan
Stock Analyst at Stifel
(1.32)
# 3,231
Out of 4,829 analysts
44
Total ratings
41.38%
Success rate
-12.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $94.44 | +21.78% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $13.75 | +103.64% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $3.14 | +27.39% | 7 | Mar 6, 2025 | |
| STAA STAAR Surgical Company | Maintains: Buy | $38 → $20 | $20.46 | -2.25% | 9 | Feb 12, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $12.12 | +48.51% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.15 | +73.91% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $94.90 | +5.37% | 4 | May 15, 2024 |
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $94.44
Upside: +21.78%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $13.75
Upside: +103.64%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.14
Upside: +27.39%
STAAR Surgical Company
Feb 12, 2025
Maintains: Buy
Price Target: $38 → $20
Current: $20.46
Upside: -2.25%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $12.12
Upside: +48.51%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.15
Upside: +73.91%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $94.90
Upside: +5.37%